Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Swart

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Rheumatology (Oxford, England)|December 20, 2023
Quantifying hospital-associated costs, and accompanying travel costs and productivity losses, before and after withdrawing TNF-α inhibitors in juvenile idiopathic arthritisAnna A Florax, Martijn J H Doeleman, Sytze de Roock, et al.
Arthritis Care & Research|April 3, 2025
Monitoring of Juvenile Idiopathic Arthritis-Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in ChildhoodIvan Foeldvari, Ameenat Solebo, Harry Petrushkin, et al.
Frontiers in Psychology|August 16, 2021
Parent-Child Dyadic Coping and Quality of Life in Chronically Diseased ChildrenMerel M Nap-van der Vlist, Reine C van der Wal, Eva Grosfeld, et al.
Pediatric Rheumatology Online Journal|July 23, 2022
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritisLuiza R Grazziotin, Gillian Currie, Marinka Twilt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 28, 2021
Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic ArthritisChiara Trincianti, Evert Hendrik Pieter Van Dijkhuizen, Alessandra Alongi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2025
Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification CriteriaRemco G A Erkens, Greta Rogani, Laura Huber, et al.
Pediatric Rheumatology Online Journal|August 8, 2024
Uncovering the hidden socioeconomic impact of juvenile idiopathic arthritis and paving the way for other rare childhood diseases: an international, cross-disciplinary, patient-centered approach (PAVE Consortium)Deborah A Marshall, Brittany Gerber, Gillian R Currie, et al.
Lupus Science & Medicine|February 10, 2022
Nailfold capillary scleroderma pattern may be associated with disease damage in childhood-onset systemic lupus erythematosus: important lessons from longitudinal follow-upDieneke Schonenberg-Meinema, Sandy C Bergkamp, Amara Nassar-Sheikh Rashid, et al.
Archives of Disease in Childhood|November 22, 2019
Daily life participation in childhood chronic disease: a qualitative studyMerel M Nap-van der Vlist, Marijke C Kars, Emma E Berkelbach van der Sprenkel, et al.
Rheumatology (Oxford, England)|December 4, 2020
A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritisJoeri W van Straalen, Gabriella Giancane, Yasmine Amazrhar, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Rheumatology (Oxford, England)|December 20, 2023
Quantifying hospital-associated costs, and accompanying travel costs and productivity losses, before and after withdrawing TNF-α inhibitors in juvenile idiopathic arthritisAnna A Florax, Martijn J H Doeleman, Sytze de Roock, et al.
Arthritis Care & Research|April 3, 2025
Monitoring of Juvenile Idiopathic Arthritis-Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in ChildhoodIvan Foeldvari, Ameenat Solebo, Harry Petrushkin, et al.
Frontiers in Psychology|August 16, 2021
Parent-Child Dyadic Coping and Quality of Life in Chronically Diseased ChildrenMerel M Nap-van der Vlist, Reine C van der Wal, Eva Grosfeld, et al.
Pediatric Rheumatology Online Journal|July 23, 2022
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritisLuiza R Grazziotin, Gillian Currie, Marinka Twilt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 28, 2021
Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic ArthritisChiara Trincianti, Evert Hendrik Pieter Van Dijkhuizen, Alessandra Alongi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2025
Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification CriteriaRemco G A Erkens, Greta Rogani, Laura Huber, et al.
Pediatric Rheumatology Online Journal|August 8, 2024
Uncovering the hidden socioeconomic impact of juvenile idiopathic arthritis and paving the way for other rare childhood diseases: an international, cross-disciplinary, patient-centered approach (PAVE Consortium)Deborah A Marshall, Brittany Gerber, Gillian R Currie, et al.
Lupus Science & Medicine|February 10, 2022
Nailfold capillary scleroderma pattern may be associated with disease damage in childhood-onset systemic lupus erythematosus: important lessons from longitudinal follow-upDieneke Schonenberg-Meinema, Sandy C Bergkamp, Amara Nassar-Sheikh Rashid, et al.
Archives of Disease in Childhood|November 22, 2019
Daily life participation in childhood chronic disease: a qualitative studyMerel M Nap-van der Vlist, Marijke C Kars, Emma E Berkelbach van der Sprenkel, et al.
Rheumatology (Oxford, England)|December 4, 2020
A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritisJoeri W van Straalen, Gabriella Giancane, Yasmine Amazrhar, et al.
Pageof 12